Zoetis Inc. (ZTS)

Sector: Healthcare
Industry: Pharmaceutical Preparations
Country: United States
Exchange: NYSE
Market cap: $31.87B

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Latest financial period: June 30, 2026
Filed with the SEC: August 6, 2026
Estimated earnings date: November 3, 2026

Menu

Home

Compare

Next Earnings Reports

How this site works

Terms of use

About